Imara (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- March 18, 2019
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $63,000,000
Company Info
- Founders
- Rahul D. Ballal
- Company Description
- Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.
- Market
- Sickle Cell Disease and Hemoglobinopathies
- Location
- Cambridge, MA, USA
- Coinvestors
- Alexandria Venture Investments, Arix Bioscience, Bay City Capital, Lundbeckfond Ventures, New Enterprise Associates, OrbiMed Advisors, Pfizer Strategic Investments Group, RA Capital, Rock Springs Capital